Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 263.0M | 225.5M | 268.4M | 228.8M |
| Cost of revenue | 99.8M | 88.3M | 107.4M | 90.1M |
| Gross profit | 163.3M | 137.2M | 160.9M | 138.7M |
| Operating expense | ||||
| Research & development | 26.1M | 22.9M | 20.7M | 19.4M |
| Selling general and admin | 126.7M | 110.4M | 116.9M | 115.2M |
| Other operating expenses | — | — | — | — |
| Operating income | -4.4M | -11.1M | 9.0M | -6.6M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 141.6K | 282.3K | 14.5K | 1.7M |
| Other income expense | -5.4M | -5.7M | -1.3M | -6.3M |
| Pretax income | -9.9M | -17.0M | 7.7M | -14.6M |
| Tax provision | 1.0M | 1.4M | -5.3M | 170.6K |
| Net income | -10.9M | -18.4M | 13.0M | -14.8M |
| Basic EPS | -0.1 | -0.1 | 0.1 | -0.1 |
| Diluted EPS | -0.1 | -0.1 | 0.1 | -0.1 |
| Basic average shares | 202.4M | 181.3M | 176.0M | 160.2M |
| Diluted average shares | 202.4M | 181.3M | 213.5M | 160.2M |
| EBITDA | 5.1M | 1.0M | 25.1M | 1.7M |
| Net income from continuing op. | -10.9M | -18.4M | 13.0M | -14.8M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |